Filing Details
- Accession Number:
- 0000937556-16-000373
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-10-04 16:22:27
- Reporting Period:
- 2016-09-30
- Filing Date:
- 2016-10-04
- Accepted Time:
- 2016-10-04 16:22:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1575205 | Samuel Thomas Mcclenahan | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Evp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-09-30 | 10,000 | $34.79 | 10,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-09-30 | 10,000 | $59.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2016-09-30 | 10,000 | $0.00 | 10,000 | $34.79 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-04-29 | 2021-04-29 | No | 4 | M | Direct |
Footnotes
- The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of September 12, 2016, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- This option was granted on April 29, 2011 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.